Our Technologies

Read about our available technologies and get in touch with our team

Filter

Sectors

Industries

Clear all filters

Electrochemical separation and recovery of materials from spent Li-ion batteries (LIBs)

Electrochemical reactors for recovering all the critical materials from LIB cathodes, including lithium, manganese, nickel, and cobalt.
Further information on this technology

Microbubble-contrast ultrasound imaging of microvasculature to treat male and female reproductive disorders

Advanced ultrasound imaging biomarkers and automated image processing to diagnose fertility pathologies in male and female reproductive organs
Further information on this technology

Polypeptide “Warhead” Targeting MYC for Cancer Therapy

A polypeptide-based ('bioPROTAC') technology designed to degrade the MYC oncoprotein inside cells, applicable in cancer treatment and prevention
Further information on this technology

PolSpec: versatile optical spectral imaging

A versatile polarisation-based detection approach for (hyper)spectral imaging and classification of samples
Further information on this technology

High power single mode nanolaser arrays

A high-powered, single mode nanolaser technology for integrated photonic communication chips and LIDAR systems.
Further information on this technology

citrOgen - the first universal presentation platform for bacterial antigens

A platform for rapidly generating antibodies against diverse bacterial targets, applicable to monoclonal antibody development and the expedited evaluation of potential vaccine antigens
Further information on this technology

Enhancing quantum memories by means of Light-Matter Interference (EEVI)

Improving existing quantum memory protocols by increasing storage and retrieval efficiencies without increasing control power or optical depth
Further information on this technology

Non-Pneumatic Particle Jamming for Low-Cost, Compact Haptic Feedback Devices

Alternative methods for particle jamming to create simulated hardness in haptic feedback devices at lower cost compared to pneumatic systems
Further information on this technology

In situ RTQuIC seeding amplification assay for neurodegeneration

A seeding amplification assay with spatial resolution that visualises protein misfolding and aggregation in intact biological samples to study the mechanisms of neurodegeneration and cross-seeding between diseases.
Further information on this technology

Assay to detect active viral infection

Mass spectrometry assay measuring 3'-deoxy-3',4'-didehydro-cytidine (ddhC) to quantitatively detect active viral infections
Further information on this technology

Sign up for updates

Sign up for monthly technology alerts via email, and find other ways to connect with us.

Sign up now

Licensing and IP performance 2019/20

Inventions disclosed

Imperial inventors submitted 250 invention disclosures to our IPC team during the year

Active licences

Imperial College London's licensing portfolio comprises 244 licences

Patents filed

Imperial filed 137 patents (including PCT applications) during the year

Patent portfolio

Imperial's patent portfolio reached 331 patents during the year

Upcoming Events

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Latest News

Accelerated development of a potential treatment for cystic fibrosis

Accelerated development of a potential treatment for cystic fibrosis

22/10/21

The UK Cystic Fibrosis Gene Therapy Consortium (GTC) is one of the partners in a licensing agreement with Boehringer Ingelheim. Find out more

Natural Killer – licensing a cell therapy

Natural Killer – licensing a cell therapy

02/09/21

Imperial has licensed iNKT cell technology based on research by Prof. Tassos Karadimitris to SUDA Pharmaceuticals. Find out more

Imperial partner Apollo receives £100m to boost medical research at leading unis

Imperial partner Apollo receives £100m to boost medical research at leading unis

17/06/21

Imperial will benefit from continued support for translational biomedical research under a unique technology transfer model. Find out more

Loading...